SLC7A11 and neoplasm: As shown in Fig. 5E, F, although RSL3 treatment caused an adaptive activation of the SIRT3-SLC7A11 axis, ferroptosis was still induced in vivo and hence resulted in significant slowing of GBM tumor growth.